Is IMAR or ABBV a better dividend investment in 2026?

IMAR currently yields 6.97% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: IMAR offers higher current income.

What is the dividend yield difference between IMAR and ABBV?

IMAR has a forward dividend yield of 6.97% ($2.00/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 3.30 percentage points.

Home › Compare › IMAR vs ABBV

IMAR vs ABBV: Dividend Comparison 2026

IMAR yields 6.97% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ABBV wins by $8.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMAR

● Live price

6.97%

Share price

$28.71

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.7K

Annual income

$1,084.33

Full IMAR calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — IMAR vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMAR	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMAR + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

IMAR pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMAR

Annual income on $10K today (after 15% tax)

$592.13/yr

After 10yr DRIP, annual income (after tax)

$921.68/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, ABBV beats the other by $59.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMAR + ABBV for your $10,000?

IMAR: 50%ABBV: 50%

100% ABBV50/50100% IMAR

Portfolio after 10yr

$35.8K

Annual income

$1,119.39/yr

Blended yield

3.13%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

IMAR

No analyst data

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMAR buys

ABBV buys

No recent congressional trades found for IMAR or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMARABBV

Forward yield	6.97% ✓	3.67%
Annual dividend / share	$2.00	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$31.7K	$39.9K ✓
Annual income after 10y	$1,084.33	$1,154.43 ✓
Total dividends collected	$8.9K ✓	$7.2K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: IMAR vs ABBV ($10,000, DRIP)

Year	IMAR Portfolio	IMAR Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$11,397	$696.62	$11,520	$399.75	$123.00 → ABBV
2	$12,936	$741.97	$13,261	$450.98	$325.00 → ABBV
3	$14,629	$787.12	$15,255	$508.41	$626.00 → ABBV
4	$16,485	$831.88	$17,536	$572.74	$1.1K → ABBV
5	$18,515	$876.09	$20,145	$644.78	$1.6K → ABBV
6	$20,731	$919.60	$23,126	$725.38	$2.4K → ABBV
7	$23,144	$962.29	$26,532	$815.52	$3.4K → ABBV
8	$25,768	$1,004.04	$30,420	$916.26	$4.7K → ABBV
9	$28,617	$1,044.75	$34,855	$1,028.80	$6.2K → ABBV
10	$31,704	$1,084.33	$39,914	$1,154.43	$8.2K → ABBV

IMAR vs ABBV: Complete Analysis 2026

IMAR — Stock

The Innovator International Developed Power Buffer ETF seeks to track the return of the iShares MSCI EAFE ETF (EFA), up to a predetermined cap, while buffering investors against the first 15% of losses over the outcome period. The ETF can be held indefinitely, resetting at the end of each outcome period, approximately annually.

Full IMAR Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this IMAR vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMAR vs SCHD IMAR vs JEPI IMAR vs O IMAR vs KO IMAR vs MAIN IMAR vs JNJ IMAR vs MRK IMAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.